A new study published in the Journal of Clinical Investigation has found that diabetes, arteriosclerosis and asthma are all linked by a single protein, called aP2.
The study was carried out by Australian and American researchers. They found that the protein, which has no useful function in the body, negatively affects blood sugar levels and fatty acid metabolism . The protein only appears to develop in healthy people during the stages of a disease .
A co-author of the paper, Dr Hotamisligil of the Harvard School of Public Health in Bosto, said that: “The exciting thing about this study is that perhaps the way all of these diseases are connected is through the inflammatory responses controlled by this boring little protein.”
Using genetically engineered mice, researchers uncovered how the protein affects the body. Human trials are in sight, according to researchers, although they are still several years away.
Another expert concluded: “This research may lead to future therapy to regulate or control excessive inflammation in the airway that can be associated with other forms of respiratory problems: rhinitis as well as asthma. But it’s obviously preliminary data, and we need to wait for further data based upon clinical trials of drugs that work on this protein.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…